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An N-terminal fragment of human SHARPIN was recombinantly expressed in
Escherichia coli, purified and crystallized. Crystals suitable for X-ray diffraction
were obtained by a one-step optimization of seed dilution and protein
concentration using a two-dimensional grid screen. The crystals belonged to
the primitive tetragonal space group P43212, with unit-cell parameters
a = b = 61.55, c = 222.81 A˚. Complete data sets were collected from native
and selenomethionine-substituted protein crystals at 100 K to 2.6 and 2.0 A˚
resolution, respectively.
1. Introduction
SHARPIN (SHANK-associated RH-domain interacting protein) is a
cytosolic 45 kDa protein that was originally identified as a scaffolding
partner for SHANK proteins in the postsynaptic density of excitatory
synapses (Lim et al., 2001). Recently, it has been shown that
SHARPIN also plays an important role in immunity and inflamma-
tion by stimulating the formation of linear ubiquitin chains.
SHARPIN is a constituent of the linear ubiquitin chain-assembly
complex (LUBAC) and the absence of SHARPIN causes dysregu-
lation of NF-B and apoptotic signalling pathways (Ikeda et al., 2011;
Gerlach et al., 2011; Tokunaga et al., 2011). The C-terminal half of
SHARPIN consists of an ubiquitin-like (Ubl) domain followed by
an Npl4-zinc finger (NZF) domain and is important for complex
formation with the LUBAC component HOIP (haem-oxidized iron-
regulatory protein 2 ubiquitin ligase-1 interacting protein) and with
ubiquitin (Ikeda et al., 2011; Gerlach et al., 2011; Tokunaga et al.,
2011). The N-terminus of SHARPIN has been reported to mediate
homomultimerization (Lim et al., 2001). However, the structural basis
of SHARPIN self-association has not been investigated. To obtain
insight into the oligomeric state of SHARPIN, we crystallized resi-
dues 1–127 encompassing the region responsible for self-association.
2. Experimental
2.1. Overexpression and purification
Human SHARPIN 1–127 was cloned into pGEX-4T1 (GE
Healthcare) by PCR with the primers Spn1-BamHI (CGCGGATC-
CATGGCGCCGCCAGCG) and Spn127-EcoRI (GCGGAATTCC-
TAGCTGCCATTCTGTCC). Because this fragment of SHARPIN
only contained the N-terminal methionine, two additional methio-
nines were introduced at positions 22 and 101 for selenomethionine
(SeMet) derivatization. The L22M/L101M mutant was generated by
site-directed mutagenesis with the primers Spn-L22M (GCCGCA-
GTGCTCATGGCTGTGCACG) and Spn-L101M (CCTGGAACC-
CTCAGCATGCACTTCCTCAACC) according to the QuikChange
protocol (Stratagene) and was verified by DNA sequencing. Wild-
type and mutant constructs were expressed as GST-fusion proteins
using Escherichia coli BL21 as a bacterial expression strain in Luria–
Bertani broth or SeMet-substituted medium (Molecular Dimensions
Ltd) containing 100 mg ml1 ampicillin. The purification procedure
was the same for the wild-type and SeMet proteins. Cells were grown
to an OD600 of 1.2 at 310 K and were induced with 0.1 mM isopropyl
-d-1-thiogalactopyranoside (IPTG). After 16 h expression at 298 K,
the cell pellets were resuspended in buffer A (100 mM HEPES pH
7.4, 500 mM NaCl, 1 mM DTT) and lysed by sonication. The lysate
was cleared by centrifugation and loaded onto a column containing
25 ml Glutathione Sepharose Fast Flow medium (GE Healthcare).
The immobilized fusion protein was extensively washed with bufferA
before the GST tag was cleaved overnight with five units of thrombin
per milligram of fusion protein. The cleaved protein was further
purified by gel filtration on a Superdex S75 column (GE Healthcare)
with buffer B (50 mM HEPES pH 7.4, 150 mM NaCl, 1 mM DTT)
as the elution buffer. 1 l medium typically yielded 12 mg purified
SHARPIN. The protein was concentrated to a final concentration of
60 mg ml1, flash-cooled in liquid nitrogen and stored at 193 K.
2.2. Crystallization
Screening experiments were carried out in 96-reservoir two-well
plates (Swissci, Molecular Dimensions Ltd) using an Oryx8 crystal-
lization robot (Douglas Instruments Ltd). Sitting drops were
prepared by mixing 100 nl protein solution at 10 mg ml1 (diluted
with buffer B) with an equal volume of screen solution and equili-
brating against 75 ml reservoir solution at 291 K. The first screen used
was a simple systematic soluble protein crystallization screen. This
was a modification of the ‘Imperial College Screen’ (Haire, 1999),
which sampled a range of precipitants, varying both concentration
and pH, to assess the solubility behaviour of the protein under
various conditions. Ammonium sulfate and polyethylene glycol
(PEG) 3350, representing the most commonly used precipitants, were
screened in the ranges 1.0–2.3M and 5–25%(w/v), respectively, with
0.1M sodium acetate pH 4.6, 0.1MMES pH 6.0, 0.1M PIPES pH 6.8,
0.1M HEPES pH 7.5 or 0.1M Tris–HCl pH 8.3. PEG 3350 at
20%(w/v) was also screened with either 0.2M ammonium acetate or
lithium sulfate at the same pH values. Other precipitants in this
screen included sodium potassium phosphate pH 7.5 at 1.4–2.4M,
PEG 400 at 25–40%(v/v), 2-methyl-2,4-pentanediol at 10–50%(v/v)
and propan-2-ol at 5–40%(v/v), all with 0.1M HEPES pH 7.5. The
original screen was expanded to 96 conditions by the addition of
triammonium citrate conditions at concentrations varying from 1 to
1.6M at pH 5.5, 6.5, 7.5 and 8.5.
The plate was imaged using an RI54 imager (Formulatrix, USA)
immediately after setup and the drops were evaluated by their
appearance: whether they remained clear, precipitated or showed
phase separation. In this screen, salts showed the most promising
trends, with clear drops progressing to white precipitate. PEG gave
denatured brown precipitate under most conditions. On the basis of
these observations, a sparse-matrix salt screen (72 conditions) was
selected for further screening. This was designed by selecting a range
of salt conditions from commercially available sparse-matrix screens
and reformatting them into a new salt screen. It contained the anions
sulfate, phosphate, citrate, tartrate, formate, acetate and malonate,
and the cations ammonium, sodium, potassium, lithium and magne-
sium, with a range of different buffers from pH 4.2 to 9.55.
The only crystals obtained with this screen were from 4M sodium
formate (no added buffer), where an air bubble was initially present
in the drop (Fig. 1). After 12 h, crystals could be observed nucleating
near the bubble. These crystals grew and after 3 d the bubble had
disappeared. Another drop set up at the same time with 4M sodium
formate but in a different screen remained clear, indicating that the
bubble may have facilitated nucleation. A crystal was X-rayed to
confirm that it was protein and the remaining crystals in the drop
were then used for preparation of a microseed solution. No crystals
were obtained from any of the other initial screens.
Traditionally, refinement of crystallization conditions to optimize
crystal size and quality is carried out using a strategy such as the ‘grid
screen’ described by Cox & Weber (1988). This approach involves
successive automated vapour-diffusion experiments in which the
precipitant concentration and solution pH are varied in a systematic
fashion from an initial coarse grid screen to finer grids. The time
required to prepare the appropriate reservoir solutions for the series
of grid screens is a drawback of this method. The novel optimization
technique described here is a one-step procedure that requires the
preparation of only one solution for all of the reservoirs of the
crystallization plate, resulting in a considerable time saving. In this
two-dimensional grid screen, variation of both protein concentration
and seed dilution in the crystallization droplet is used for refinement
of growth conditions, rather than variation of the chemical compo-
nents (Cox & Weber, 1988). An increase in drop volume from 0.2 to
0.6 ml facilitates crystal removal from the drop and allows larger
crystals to grow over time. This method has proved successful in the
reproducible growth of diffracting crystals for SHARPIN.
The two-dimensional grid microseeding screen (Haire, 2011) uses a
script (Douglas Instruments Ltd) where two variables may be varied
simultaneously, e.g. protein concentration across the plate (X) and
additive concentration or seed stock up and down the plate (Y).
Droplets consisted of a total volume of 0.6 ml. The protein concen-
tration in the drop was varied from 2.5 to 5 mg ml1 (in eight
increments of 0.35 mg ml1) by addition of buffer B as a diluent along
the X axis of the Swissci plate. The volume of seed solution varied
from 0 to 100 nl (in 12 increments of 9 nl) by addition of 4M sodium
formate as a diluent along the Y axis. All reservoirs contained 75 ml
4M sodium formate. Plates were sealed with clear tape from
Hampton Research and incubated at 291 K in the RI54 imager.
Images were collected every 12 h for the first 4 d (Fig. 2).
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Figure 1
Time course of crystal growth from day 1 to day 3. The scale bar represents 0.2 mm.
Native protein and seeds were used in a two-dimensional grid
screen to obtain native SHARPIN crystals. The seed-stock solution
was prepared by crushing the crystals with a microtool (Hampton
Research, USA) and transferring them into an Eppendorf tube
containing a bead (using the Seed Bead kit from Hampton Research)
with 50 ml 4M sodium formate as a stabilizing solution. The crystals
were then mechanically homogenized on a standard laboratory
vortex mixer for 3 min at full speed (D’Arcy et al., 2007).
SeMet SHARPIN crystals were obtained using the same two-
dimensional grid procedure (with 4M sodium formate as reservoir
solution) and seeding the SeMet protein with the native seeds (Fig. 3).
2.3. Data collection
Crystals were harvested from the drop with a cryoloop (Hampton
Research) and flash-cooled in liquid nitrogen using 4M sodium
formate supplemented with 10%(v/v) glycerol as a cryoprotectant. A
native data set was collected to a resolution of 2.6 A˚ at 100 K using a
Rigaku MicroMax-007 HF with an R-AXIS IV detector. In order to
solve the phase problem, a second data set was collected from a
SeMet SHARPIN crystal at 100 K on beamline I04 at the Diamond
Light Source (Didcot, England) at a wavelength of 0.9799 A˚ using an
ADSC Q315r detector. A redundant data set of 90 frames with an
oscillation range of 1 was collected (Fig. 4). The diffraction limit of
the crystal was 2.0 A˚. Data were indexed, integrated and scaled using
the HKL-2000 package (Otwinowski & Minor, 1997). Systematic
absences revealed that the crystals of SHARPIN 1–127 belonged to
the primitive tetragonal space group P43212 or P41212, with unit-cell
parameters a = b = 61.55, c = 222.81 A˚ (Table 1).
3. Results and discussion
There are four molecules per asymmetric unit, corresponding to a
Matthews coefficient VM of 2.03 A˚
3 Da1 and a solvent content of
39.57% (Matthews, 1968). Structure determination by single-
wavelength anomalous dispersion analysis has been described by
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Figure 2
Typical crystals of native SHARPIN obtained using the two-dimensional grid
seeding method with 4M sodium formate as precipitant. The crystallization drop
(0.6 ml) contained 3.9 mg ml1 SHARPIN (final concentration) with the addition of
45 nl native seed solution in 4M sodium formate. The scale bar represents 0.1 mm.
Figure 3
A typical crystal of SeMet SHARPIN grown by cross-seeding with native seeds in a
two-dimensional grid experiment. The crystallization drop (0.6 ml) contained
3.9 mg ml1 SeMet SHARPIN (final concentration) with the addition of 9 nl native
seed solution in 4M sodium formate and was equilibrated against a reservoir
consisting of 4M sodium formate. The scale bar represents 0.1 mm.
Figure 4
Representative X-ray diffraction image of a SeMet-SHARPIN crystal collected on
the I04 beamline at the Diamond Light Source (Didcot, England). The crystal
diffracted to 2.0 A˚ resolution (crystal-to-detector distance 289.53 mm).
Table 1
Data-collection statistics.
Values in parentheses are for the highest resolution shell.
Native SeMet
Source In-house Diamond I04
Wavelength (A˚) 1.5418 0.9799
Resolution (A˚) 30–2.6 (2.69–2.60) 30–2.0 (2.09–2.00)
Space group P43212/P41212 P43212/P41212
Unit-cell parameters (A˚) a = b = 61.396, c = 222.431 a = b = 61.55, c = 222.81
VM (A˚
3 Da1) 2.02 2.03
Total measurements 169348 213897
Unique reflections 13876 55100†
Average multiplicity 12.2 (11.5) 3.9 (3.8)
hI/(I)i 17.9 (2.7) 17.2 (2.9)
Completeness (%) 99.0 99.1
Wilson B factor (A˚2) 59.8 39.1
Rmerge‡ (%) 9.8 (62.0) 7.1 (48.3)
† Friedel pairs are treated as separate reflections. ‡ Rmerge =P
hkl
P




i IiðhklÞ, where hI(hkl)i is the average intensity of
multiple Ii(hkl) observations of symmetry-related reflections.
Stieglitz et al. (2012). The structure factors and coordinates have been
deposited in the Protein Data Bank (PDB entry 4emo).
Crystals appeared rapidly (within a day) using the two-dimensional
grid method and were used for native data collection after 4 d. A
control experiment was set up using 4M sodium formate instead of
microseed solution. No crystals grew, indicating that the introduction
of seeds caused nucleation rather than the chemical bias resulting
from the addition of mother liquor to the drop (St John et al., 2008). It
seems that an element of serendipity was involved in the nucleation
of the original crystals at the site of the air bubble. No other
heterogeneous nucleant, such as a piece of dust, was observed on the
surface of the bubble. The use of these crystals as seeds in the two-
dimensional grid screen increased the reproducibility of crystal
growth.
Cross-seeding SeMet SHARPIN with native seeds (Stura &
Wilson, 1992) using the two-dimensional grid screen resulted in the
rapid growth of diffracting SeMet SHARPIN crystals in a one-step
procedure.
The two-dimensional grid optimization strategy presented here has
proved effective for the reproducible growth of diffracting native and
SeMet SHARPIN crystals.
The authors are grateful to Katharina Berchner for excellent
assistance. This work was supported by the Medical Research Council
UK, grant U117565398. We are grateful to Philip Walker for data
collection.
References
Cox, M. J. & Weber, P. C. (1988). J. Cryst. Growth, 90, 318–324.
D’Arcy, A., Villard, F. & Marsh, M. (2007). Acta Cryst. D63, 550–554.
Gerlach, B. et al. (2011). Nature (London), 471, 591–596.
Haire, L. F. (2011). Fast Optimization: 2-D Grid Seeding Method. Recent
Advances in Macromolecular Crystallization 2011 Poster Abstracts, P13.
http://hamptonresearch.com/documents/ramc/RAMC2011_P13_Haire.pdf.
Haire, L. L. (1999). Protein Crystallization, edited by T. Bergfors, pp. 125–129.
La Jolla: International University Line.
Ikeda, F. et al. (2011). Nature (London), 471, 637–641.
Lim, S., Sala, C., Yoon, J., Park, S., Kuroda, S., Sheng, M. & Kim, E. (2001).
Mol. Cell. Neurosci. 17, 385–397.
Matthews, B. W. (1968). J. Mol. Biol. 33, 491–497.
Otwinowski, Z. & Minor, W. (1997). Methods Enzymol. 276, 307–326.
Stieglitz, B., Haire, L. F., Dikic, I. & Rittinger, K. (2012). J. Biol. Chem. 287,
20823–20829.
St John, F. J., Feng, B. & Pozharski, E. (2008). Acta Cryst. D64, 1222–
1227.
Stura, E. A. & Wilson, I. A. (1992). Crystallization of Nucleic Acids and
Proteins: A Practical Approach, edited by A. Ducruix & R. Giege´, pp. 99–
126. Oxford University Press.
Tokunaga, F., Nakagawa, T., Nakahara, M., Saeki, Y., Taniguchi, M., Sakata, S.,
Tanaka, K., Nakano, H. & Iwai, K. (2011). Nature (London), 471, 633–
636.
crystallization communications
Acta Cryst. (2012). F68, 816–819 Stieglitz et al.  SHARPIN 819
